Search

Displaying results 8731 - 8740 of 10000 in total
  1. Drug

    Evocalcet

    go.drugbank.com/drugs/DB12388
    Investigational

    Evocalcet has been used in trials studying the treatment of Hyperparathyroidism and Secondary Hyperparathyroidism.

  2. Drug

    MK-3207

    go.drugbank.com/drugs/DB12424
    Investigational

    Mk3207 has been used in trials studying the treatment of Migraine and Migraine Disorders.

  3. Drug

    Batefenterol

    go.drugbank.com/drugs/DB12526
    Investigational

    Batefenterol has been used in trials studying the treatment of Pulmonary Disease, Chronic Obstructive.

  4. Drug

    Netivudine

    go.drugbank.com/drugs/DB12606
    Investigational

    Netivudine has been used in trials studying the treatment of Chickenpox and HIV Infections.

  5. Drug

    Nona-arginine

    go.drugbank.com/drugs/DB12648
    Investigational

    Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).

  6. Drug

    Letosteine

    go.drugbank.com/drugs/DB08939
    Experimental

    Letosteine is a mucolytic used in the treatment of chronic bronchopneumopathies and related conditions.

  7. Drug

    Halofuginone

    go.drugbank.com/drugs/DB04866
    InvestigationalVet approved

    Food and Drug Administration in March, 2000. … Halofuginone also effectively suppresses tumor progression and metastasis in mice.

  8. Drug

    (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid

    go.drugbank.com/drugs/DB03455
    Experimental

    These are compounds containing an acetic acid (or a derivative) linked to the C3 carbon atom of an indole. (1H-indol-3-yl)-(2-mercapto-ethoxyimino)-acetic acid is known to target interleukin-2.

  9. Drug

    Cixutumumab

    go.drugbank.com/drugs/DB12250
    Investigational

    IGF-IR is overexpressed in a variety of tumour types. … Cixutumumab has been used in trials studying the treatment of Lung Cancer, Malignant Neoplasm, Leukemia, Mast-Cell, Non-Small-Cell Lung Carcinoma, and Adenocarcinoma of the Prostate.

  10. Drug

    AZD3409

    go.drugbank.com/drugs/DB04893
    Experimental

    AZD3409 is a farnesyl-transferase inhibitor (FAR) indicated for the treatment of solid tumors. Phase I trials were initiated January 2003, and were ongoing as of February 2004. As of February 2007 the development of AZD3409 had been disc...